SCHEMBL18502983

SCHEMBL18502983

Cc1ccc(/C=N\O)c(F)c1Cl

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
MAPT P10636 5/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
FGF23 Q9GZV9 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
RAB9A P51151 1/20 0.36
HPGD P15428 6/20 0.35
TSHR P16473 2/20 0.35
LMNA P02545 3/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HTT P42858 3/20 0.33
HSD17B10 Q99714 2/20 0.33
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18508600 1.00 ALDH1A1 (0.38) ALDH1A1MAPTL3MBTL1KDM4EGAA
SCHEMBL18502962 0.82 HPGD (0.38) ALDH1A1MAPTL3MBTL1KDM4EGAA
SCHEMBL18508559 0.82 HPGD (0.38) ALDH1A1MAPTL3MBTL1KDM4EGAA
SCHEMBL18508599 0.81 L3MBTL1 (0.36) ALDH1A1MAPTL3MBTL1KDM4EGAA
SCHEMBL18302417 0.81 L3MBTL1 (0.36) ALDH1A1MAPTL3MBTL1KDM4EGAA
SCHEMBL18502963 0.81 HTT (0.38) ALDH1A1MAPTL3MBTL1KDM4EGAA
SCHEMBL18502961 0.81 L3MBTL1 (0.36) ALDH1A1MAPTL3MBTL1KDM4EGAA
SCHEMBL18508495 0.81 HTT (0.38) ALDH1A1MAPTL3MBTL1KDM4EGAA
SCHEMBL30683502 0.81 L3MBTL1 (0.36) ALDH1A1MAPTL3MBTL1KDM4EGAA
SCHEMBL20148179 0.81 HPGD (0.37) ALDH1A1MAPTL3MBTL1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors FORUM PHARMACEUTICALS, INC. 2018-05-17 US disclosed
US-20170044155-A1 Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors AXOVANT SCIENCES GMBH (CH) 2017-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170044155-A1 Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors CHRNA7, CHRNA5, CHRNA6 ALDH1A1 2925/4885MAPT 1241/4885L3MBTL1 3087/4885
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors CHRNA7, CHRNA5, CHRNA2 ALDH1A1 2821/4885MAPT 1008/4885L3MBTL1 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.